面部动脉动脉瘤:特征,治疗干预和临床结果的系统审查
Ali Rafiei1, Mahsa Moini2, Fardin Karbakhsh Ravari1
1Department of Vascular Surgery, Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Journal of maxillofacial and oral surgery
|November 27, 2025
概括
面部动脉动脉瘤是罕见的. 手术治疗的并发症比内血管方法少,尽管证据有限. 针对性管理对于这些血管异常至关重要.
科学领域:
- 血管外科 血管外科
- 干预性放射学 干预性放射学
- 医学诊断 医学诊断 医学诊断
背景情况:
- 面部动脉动脉瘤是不常见的血管病变,呈现为伪动脉瘤 (创伤后/创伤后) 或真实动脉瘤 (退化).
- 这些罕见疾病的诊断和管理策略缺乏标准化,需要对当前证据进行审查.
研究的目的:
- 系统地审查和总结关于面部动脉动脉瘤的诊断,管理和并发症的证据.
- 为指导这些罕见的血管异常的临床决策.
主要方法:
- 在PubMed,Scopus和Web of Science中按照PRISMA指南进行了系统的文献搜索.
- 包括到2024年10月发表的病例报告,病例系列和观察性研究,重点关注动脉瘤特征,诊断,治疗和结果.
主要成果:
- 分析了涉及74名患者的70项研究;阳性 (39%) 和创伤性 (36%) 原因是最常见的,主要是伪动脉瘤.
- 手术干预的成功率很高 (3.8%的并发症率),而内血管栓塞显示出更高的不良事件 (21.4%),包括栓塞事件.
- 没有确定标准化管理方法,强调基于病变特征的个性化治疗.
结论:
- 面部动脉动脉瘤需要及时诊断和量身定制的管理.
- 与内血管技术相比,手术干预似乎带来了更好的结果,并发症较少.
- 限制包括小样本大小和依赖病例报告;为制定指南需要进一步的大规模研究.
相关概念视频
01:26Aneurysm III: Interprofessional Care
245
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
245
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
240
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
240
01:26Atherosclerosis III: Management
296
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296
01:27Peripheral Artery Disease III: Interprofessional Care
226
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
226
01:27Coronary Artery Disease V: Interprofessional Care
205
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
205